Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Osteoporosis and Sarcopenia ; : 51-58, 2018.
Article in English | WPRIM | ID: wpr-741782

ABSTRACT

OBJECTIVES: An understanding of bone mineral density (BMD) pattern in a population is crucial for prevention and diagnosis of osteoporosis and management of its complications in later life. This study aimed to screen the bone health status and factors associated with osteoporosis in an apparently healthy Indian population. METHODS: A retrospective review of medical records was done in a tertiary-care hospital for the subjects who had undergone preventive health-check-ups that included BMD measurements at femur-neck, total-femur, and lumbar-spine. RESULTS: We evaluated 524 subjects (age, 50.0 ± 12.4 years) including 41.2% female and 58.8% male subjects. Osteoporosis was present in 6.9% subjects (female, 11.1%; male, 4.2%) and osteopenia in 34% subjects (female, 40.3%; male, 29.9%). Absolute BMD was higher in male subjects (P 0.05) at any site. CONCLUSIONS: Further data on absolute BMD, T scores, and prevalence rates of osteoporosis/osteopenia on multiple bone sites have been presented in this article.


Subject(s)
Female , Humans , Male , Alkaline Phosphatase , Body Mass Index , Bone Density , Bone Diseases, Metabolic , Calcium , Diagnosis , Medical Records , Motor Activity , Osteoporosis , Prevalence , Retrospective Studies , Spine
2.
Osteoporosis and Sarcopenia ; : 75-81, 2017.
Article in English | WPRIM | ID: wpr-27196

ABSTRACT

Selective serotonin reuptake inhibitors (SSRIs) are currently the treatment of choice in depression and constitute major portion of prescription in depressive patients. The role of serotonin receptors in bone is emerging, raising certain questions regarding the effect of blockade of serotonin reuptake in the bone metabolism. Clinical studies have reported an association of SSRI antidepressants which with increase in fracture and decrease in bone mineral density. This review focus on recent evidence that evaluate the association of SSRIs with the risk of fracture and bone mineral density and also the probable mechanisms that might be involved in such effects.


Subject(s)
Humans , Antidepressive Agents , Bone Density , Depression , Metabolism , Prescriptions , Receptors, Serotonin , Selective Serotonin Reuptake Inhibitors , Serotonin
3.
Hamdard Medicus. 2009; 52 (2): 54-58
in English | IMEMR | ID: emr-144957

ABSTRACT

The present study evaluated the effect of Thioperamide [THP], a selective histamine H[3]-receptor antagonist, on middle cerebral artery occlusion [MCAO]-induced focal cerebral ischemia in rats. The rats were subjected to 2 hrs of MCAO followed by 22 hrs reperfusion followed by nitrate and nitrite levels estimations in the whole brain of rats. A decrease in the level of nitrate and nitrite was observed following MCAO. THP pre-treatment could not reverse such a reduction in nitrite but slightly reversed reduced nitrate levels. The opposite effect of THP on nitrate and nitrite levels requires further investigation and raises doubts on its possible use in cerebral ischemia


Subject(s)
Animals, Laboratory , Male , Infarction, Middle Cerebral Artery , Nitric Oxide/analysis , Rats, Wistar , Brain Ischemia
SELECTION OF CITATIONS
SEARCH DETAIL